Sun Pharma strikes biopharma's largest deal of '26 with $11.75B buyout of Organon

Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition of women’s health leader Organon. With its $11.75 billion buyout, Sun has picked up a drugmaker that matched the $6.2 billion in sales that it generated in 2025.